Cytarabine
Product manufactured by Mylan Institutional Llc
Indications and Purposes
| Indications And Usage Cytarabine In Combination With Other Approved Anticancer Drugs Is Indicated For Remission Induction In Acute Non-Lymphocytic Leukemia Of Adults And Children. It Has Also Been Found Useful In The Treatment Of Acute Lymphocytic Leukemia And The Blast Phase Of Chronic Myelocytic Leukemia. Intrathecal Administration Of Cytarabine Is Indicated In The Prophylaxis And Treatment Of Meningeal Leukemia. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Cytarabine |
|
ZINC3795098 |